Stryker Total Long Term Liabilities 2010-2024 | SYK
Stryker total long term liabilities from 2010 to 2024. Total long term liabilities can be defined as the sum of all non-current liabilities.
- Stryker total long term liabilities for the quarter ending December 31, 2024 were $14.721B, a 9.87% increase year-over-year.
- Stryker total long term liabilities for 2024 were $14.721B, a 9.87% increase from 2023.
- Stryker total long term liabilities for 2023 were $13.398B, a 4.06% decline from 2022.
- Stryker total long term liabilities for 2022 were $13.965B, a 8.16% decline from 2021.
| Stryker Annual Total Long Term Liabilities (Millions of US $) |
|
|---|---|
| 2024 | $14,721 |
| 2023 | $13,398 |
| 2022 | $13,965 |
| 2021 | $15,205 |
| 2020 | $16,205 |
| 2019 | $12,960 |
| 2018 | $10,692 |
| 2017 | $8,732 |
| 2016 | $7,737 |
| 2015 | $4,210 |
| 2014 | $4,223 |
| 2013 | $4,039 |
| 2012 | $2,733 |
| 2011 | $2,623 |
| 2010 | $2,116 |
| 2009 | $1,035 |
| Stryker Quarterly Total Long Term Liabilities (Millions of US $) |
|
|---|---|
| 2024-12-31 | $14,721 |
| 2024-09-30 | $16,015 |
| 2024-06-30 | $12,442 |
| 2024-03-31 | $13,275 |
| 2023-12-31 | $13,398 |
| 2023-09-30 | $12,679 |
| 2023-06-30 | $13,464 |
| 2023-03-31 | $14,069 |
| 2022-12-31 | $13,965 |
| 2022-09-30 | $14,949 |
| 2022-06-30 | $15,954 |
| 2022-03-31 | $16,683 |
| 2021-12-31 | $15,205 |
| 2021-09-30 | $15,518 |
| 2021-06-30 | $15,626 |
| 2021-03-31 | $16,000 |
| 2020-12-31 | $16,205 |
| 2020-09-30 | $14,611 |
| 2020-06-30 | $14,324 |
| 2020-03-31 | $12,163 |
| 2019-12-31 | $12,960 |
| 2019-09-30 | $10,423 |
| 2019-06-30 | $10,465 |
| 2019-03-31 | $10,531 |
| 2018-12-31 | $10,692 |
| 2018-09-30 | $8,071 |
| 2018-06-30 | $8,064 |
| 2018-03-31 | $8,110 |
| 2017-12-31 | $8,732 |
| 2017-09-30 | $7,802 |
| 2017-06-30 | $7,705 |
| 2017-03-31 | $8,259 |
| 2016-12-31 | $7,737 |
| 2016-09-30 | $7,829 |
| 2016-06-30 | $7,817 |
| 2016-03-31 | $7,674 |
| 2015-12-31 | $4,210 |
| 2015-09-30 | $3,880 |
| 2015-06-30 | $4,591 |
| 2015-03-31 | $4,564 |
| 2014-12-31 | $4,223 |
| 2014-09-30 | $4,680 |
| 2014-06-30 | $4,514 |
| 2014-03-31 | $3,538 |
| 2013-12-31 | $4,039 |
| 2013-09-30 | $3,822 |
| 2013-06-30 | $3,808 |
| 2013-03-31 | $3,825 |
| 2012-12-31 | $2,733 |
| 2012-09-30 | $2,840 |
| 2012-06-30 | $2,821 |
| 2012-03-31 | $2,888 |
| 2011-12-31 | $2,623 |
| 2011-09-30 | $2,964 |
| 2011-06-30 | $2,215 |
| 2011-03-31 | $2,192 |
| 2010-12-31 | $2,116 |
| 2010-09-30 | $2,060 |
| 2010-06-30 | $2,020 |
| 2010-03-31 | $2,023 |
| 2009-12-31 | $1,035 |
| 2009-09-30 | $820 |
| 2009-06-30 | $791 |
| 2009-03-31 | $778 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $142.084B | $22.595B |
| Stryker Corporation is a medical device company operating in the global orthopedic market. The company has three business segments: Orthopaedics, MedSurg and Neurotechnology & Spine. Orthopaedic?products include implants used in hip and knee joint replacements and trauma and extremities surgeries. MedSurg?products consists of surgical equipment and surgical navigation systems; endoscopic and communications systems; patient handling and emergency medical equipment and reprocessed and remanufactured medical devices. Neurotechnology & Spine division includes both neurosurgical and neurovascular devices. These includes products used for minimally invasive endovascular techniques; traditional brain and open skull base surgical procedures; orthobiologic and biosurgery products and minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke. Spinal implant product offering includes cervical, thoracolumbar and interbody systems used in spinal injury, deformity and degenerative therapies. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $230.058B | 28.41 |
| Boston Scientific (BSX) | United States | $149.209B | 40.19 |
| EssilorLuxottica (ESLOY) | France | $131.854B | 0.00 |
| Medtronic (MDT) | Ireland | $115.249B | 16.83 |
| Haleon (HLN) | United Kingdom | $46.488B | 26.39 |
| Lonza Group Ag (LZAGY) | Switzerland | $44.527B | 0.00 |
| GE HealthCare Technologies (GEHC) | United States | $36.909B | 17.98 |
| Agilent Technologies (A) | United States | $33.351B | 22.03 |
| ResMed (RMD) | United States | $32.876B | 25.32 |
| Terumo (TRUMY) | Japan | $27.805B | 39.54 |
| Koninklijke Philips (PHG) | Netherlands | $23.874B | 17.05 |
| Zimmer Biomet Holdings (ZBH) | United States | $22.530B | 14.15 |
| Insulet (PODD) | United States | $18.442B | 78.86 |
| Baxter (BAX) | United States | $17.557B | 12.63 |
| Sunny Optical Technology (SNPTF) | China | $12.864B | 0.00 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $12.403B | 0.00 |
| Demant (WILYY) | Denmark | $8.048B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $6.822B | 23.62 |
| Lantheus Holdings (LNTH) | United States | $6.684B | 16.43 |
| Prestige Consumer Healthcare (PBH) | United States | $4.259B | 20.32 |
| Perrigo (PRGO) | Ireland | $3.826B | 10.95 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| ICU Medical (ICUI) | United States | $3.405B | 29.11 |
| Haemonetics (HAE) | United States | $3.193B | 15.02 |
| Envista Holdings (NVST) | United States | $2.972B | 23.64 |
| QuidelOrtho (QDEL) | United States | $2.359B | 19.76 |
| GN Store Nord (GNNDY) | Denmark | $2.336B | 15.74 |
| LeMaitre Vascular (LMAT) | United States | $1.893B | 43.25 |
| Neogen (NEOG) | United States | $1.881B | 21.67 |
| AtriCure (ATRC) | United States | $1.577B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.462B | 14.08 |
| Kestra Medical Technologies (KMTS) | $1.234B | 0.00 | |
| InMode (INMD) | Israel | $1.234B | 10.31 |
| Green Thumb Industries (GTBIF) | United States | $1.233B | 19.37 |
| BioLife Solutions (BLFS) | United States | $1.073B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.865B | 13.27 |
| Evolus (EOLS) | United States | $0.765B | 0.00 |
| Owens & Minor (OMI) | United States | $0.698B | 5.94 |
| CeriBell (CBLL) | United States | $0.689B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.601B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.562B | 0.00 |
| Valneva SE (VALN) | France | $0.545B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.478B | 20.71 |
| Omeros (OMER) | United States | $0.476B | 0.00 |
| Surmodics (SRDX) | United States | $0.436B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.433B | 0.00 |
| SNDL (SNDL) | Canada | $0.371B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.354B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.329B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.302B | 0.00 |
| ZimVie (ZIMV) | United States | $0.301B | 18.00 |
| Viemed Healthcare (VMD) | United States | $0.288B | 26.00 |
| Sanara MedTech (SMTI) | United States | $0.275B | 0.00 |
| Cerus (CERS) | United States | $0.258B | 0.00 |
| Quanterix (QTRX) | United States | $0.252B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.252B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.247B | 43.90 |
| Verano Holdings (VRNOF) | United States | $0.233B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.184B | 14.19 |
| Biote (BTMD) | United States | $0.182B | 4.16 |
| Brainsway (BWAY) | Israel | $0.178B | 55.71 |
| TriSalus Life Sciences (TLSI) | United States | $0.168B | 0.00 |
| High Tide (HITI) | Canada | $0.153B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.144B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.140B | 0.00 |
| Organigram Holdings (OGI) | Canada | $0.128B | 0.00 |
| Jin Medical (ZJYL) | China | $0.116B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.112B | 13.99 |
| Quipt Home Medical (QIPT) | United States | $0.100B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.087B | 0.00 |
| Fonar (FONR) | United States | $0.087B | 12.18 |
| MacroGenics (MGNX) | United States | $0.080B | 0.00 |
| Veru (VERU) | United States | $0.072B | 0.00 |
| Zynex (ZYXI) | United States | $0.067B | 24.44 |
| United Health Products (UEEC) | United States | $0.066B | 0.00 |
| Exagen (XGN) | United States | $0.064B | 0.00 |
| InterCure (INCR) | Israel | $0.064B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.059B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.055B | 0.00 |
| Apyx Medical (APYX) | United States | $0.052B | 0.00 |
| Modular Medical (MODD) | United States | $0.044B | 0.00 |
| ImmuCell (ICCC) | United States | $0.043B | 0.00 |
| United-Guardian (UG) | United States | $0.041B | 12.66 |
| Rockwell Medical (RMTI) | United States | $0.038B | 56.50 |
| Safety Shot (SHOT) | United States | $0.027B | 0.00 |
| INLIF (INLF) | $0.021B | 0.00 | |
| Nephros (NEPH) | United States | $0.018B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.015B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.015B | 0.00 |
| Flora Growth (FLGC) | United States | $0.012B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.010B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.009B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.008B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.006B | 0.00 |
| Agape ATP (ATPC) | $0.005B | 0.00 | |
| IM Cannabis (IMCC) | Canada | $0.003B | 0.00 |
| Senestech (SNES) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.002B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |